Edition:
United States

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

3.37USD
11:26am EDT
Change (% chg)

$-0.09 (-2.60%)
Prev Close
$3.46
Open
$3.49
Day's High
$3.50
Day's Low
$3.36
Volume
873
Avg. Vol
15,592
52-wk High
$5.55
52-wk Low
$1.22

Chart for

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for .

Overall

Beta: 0.02
Market Cap(Mil.): $39.03
Shares Outstanding(Mil.): 11.28
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 81.16 15.93
EPS (TTM): -- -- --
ROI: -- 3.20 14.60
ROE: -- 5.02 13.96

BRIEF-Cleveland BioLabs Q2 loss per share $0.50‍​

* Cleveland BioLabs reports second quarter 2017 financial results and development progress

Aug 14 2017

BRIEF-Cleveland Biolabs Inc's principal financial officer resigns

* Cleveland Biolabs Inc - ‍On May 29, John Szydlo notified co that he will resign as company's principal financial officer, effective June 16​

Jun 02 2017

BRIEF-Cleveland Biolabs Qtrly loss per share $0.15

* Cleveland Biolabs reports first quarter 2017 financial results and development progress

May 15 2017

BRIEF-Cleveland Biolabs announces European Medicines Agency positive opinion regarding entolimod pediatric investigation plan

* Cleveland Biolabs announces European Medicines Agency positive opinion regarding the entolimod pediatric investigation plan

Apr 17 2017

BRIEF-Cleveland Biolabs announces commencement of in Vivo Biocomparability study

* Cleveland Biolabs announces commencement of in Vivo biocomparability study

Apr 17 2017

Earnings vs. Estimates